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Abstract: The early indications of vitamin C deficiency are unremarkable (fatigue, 
malaise, depression) and may manifest as a reduced desire to be physically active; 
moreover, hypovitaminosis C may be associated with increased cold duration and severity. 
This study examined the impact of vitamin C on physical activity and respiratory tract 
infections during the peak of the cold season. Healthy non-smoking adult men (18–35 
years; BMI < 34 kg/m2; plasma vitamin C < 45 µmol/L) received either 1000 mg of 
vitamin C daily (n = 15) or placebo (n = 13) in a randomized, double-blind, eight-week 
trial. All participants completed the Wisconsin Upper Respiratory Symptom Survey-21 
daily and the Godin Leisure-Time Exercise Questionnaire weekly. In the final two weeks 
of the trial, the physical activity score rose modestly for the vitamin C group vs. placebo 
after adjusting for baseline values: +39.6% (95% CI [−4.5,83.7]; p = 0.10). The number of 
participants reporting cold episodes was 7 and 11 for the vitamin C and placebo groups 
respectively during the eight-week trial (RR = 0.55; 95% CI [0.33,0.94]; p = 0.04) and cold 
duration was reduced 59% in the vitamin C versus placebo groups (−3.2 days; 95% CI 
[−7.0,0.6]; p = 0.06). These data suggest measurable health advantages associated with 
vitamin C supplementation in a population with adequate-to-low vitamin C status. 
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1. Introduction 
Vitamin C status of American adults is adequate with mean plasma concentrations ranging from  
49 to 58 µmol/L for men and women, respectively [1,2]. However, 22% of U.S. adults are believed to 
have below adequate vitamin C status (plasma concentrations < 28 µmol/L), and about 6% of the adult 
population is classified as vitamin C deficient (<11 µmol/L) [2,3]. Non-supplementing men  
(20–49 years) are particularly at risk of poor vitamin C status [2]. While overt scurvy is reported 
occasionally in medical literature, poor vitamin C status is commonly undiagnosed since the early 
symptoms are nonspecific and unremarkable (e.g., fatigue, malaise, depression, and irritability) [4]. 
The fatigue and weakness of early scurvy have been attributed to defective carnitine production  
and the resultant reduction in fat oxidation [5–7]. Furthermore, vitamin C is a cosubstrate for  
dopamine-β-monooxygenase, which converts the neurotransmitter dopamine to norepinephrine [8]. 
The results of deficient neurotransmitter conversions may contribute to the depression and mood 
swings characteristic of early scurvy. 
These feelings of fatigue and malaise may manifest as a reduced desire to be physically active. 
Early reports associated preclinical vitamin C deficiency with fatigue and aversion to exercise [9–11]. 
More recently, Pincemail et al. [12] evaluated nearly 900 healthy Belgian adults (40–60 years)  
and noted a 9% higher plasma vitamin C concentration in active individuals (those reporting  
physical activity two to three times a week) versus their inactive counterparts. However, there is little 
causal experimental evidence demonstrating an influence of vitamin C supplementation on daily 
physical activity. 
Vitamin C may also reduce cold duration and severity [13]; however, this association continues to 
be highly debated. The reduction in cold duration has been linked to immune system enhancement by 
vitamin C [14]; whereas, the reduction in cold severity may be explained by the antihistamine property 
of vitamin C [15]. The 2013 Cochrane Review on vitamin C for the treatment of the common cold, 
encompassing twenty-nine trials with 11,306 research participants, did not observe a benefit of  
vitamin C supplementation on the incidence of colds in the general population, but a clear benefit of 
vitamin C supplementation for reducing the incidence of colds for individuals at times of extreme 
physical stress was noted (RR 0.48; 95% CI 0.35 to 0.64) [16]. 
The use of validated measures for assessing physical activity and respiratory tract symptoms is 
lacking in much of the published research on vitamin C supplementation and health outcomes. 
Furthermore, contradictions in the published research regarding benefits of vitamin C supplementation 
on common cold incidence and severity may be attributed in part to the vitamin C nutriture of the 
research participants at study entry [13]. The objective of this study was to determine the impact of 
vitamin C supplementation (1000 mg daily for eight weeks) on both physical activity levels and 
symptoms of upper respiratory tract infections in young men with marginal vitamin C status during the 
peak of the cold season (January to April). Validated measures, the Godin-Leisure Time Exercise 
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Questionnaire and the Wisconsin Upper Respiratory Symptom Survey, were used to track change in 
physical activity and cold symptoms over the course of the trial. 
2. Experimental Section 
2.1. Participants 
Healthy, nonsmoking men (n = 43; 18–35 years; BMI < 34 kg/m2) who did not engage in exercise 
training for competitive sports or use prescription medications were recruited from a large college 
campus in the Southwestern United States. Those regularly taking supplements or consuming foods 
fortified with over 60 mg vitamin C per serving were excluded. Qualifying volunteers provided written 
informed consent, and a postprandial venous blood sample (no food or drink with the exception of 
water for at least 5 h) was collected for vitamin C analysis. Individuals with plasma vitamin C 
concentrations less than 45 µmol/L were eligible to participate in the randomized study. These men  
(n = 30) were paired by age, BMI, and plasma vitamin C concentration and randomly assigned by a 
coin toss to the vitamin C group or the placebo group. The study was approved by the Institutional 
Review Board at Arizona State University and incorporates theses research conducted by Masters 
Students at Arizona State University [17,18]. This trial was not registered at an International 
Committee of Medical Journal Editors registry. 
2.2. Study Design 
This randomized, double-blind, placebo-controlled study followed a parallel arm design and lasted 
eight weeks. Participants were instructed to restrict all juice or fruit-flavored drinks during the study 
period, and to ingest two capsules daily in a divided dose (morning and evening). Vitamin C capsules 
(500 mg vitamin C per capsule, Twinlab C-500 CAPS, American Fork, UT, USA) were identical in 
appearance to the placebo capsules that contained white flour. All capsules were packaged in  
re-sealable storage bags. The randomization was conducted by the lead investigator who did not have 
contact with participants or conduct data entry or blood analyses. Participants were provided a booklet 
at the start of the study that contained the Wisconsin Upper Respiratory Symptom Survey-21, the 
Godin Leisure-Time Exercise Questionnaire, and a short food frequency measure. Participants 
completed the symptom survey daily, and the exercise and food frequency measures were completed 
weekly. The booklets contained materials to cover a 4-week time frame. At study week 4, participants 
received a second booklet to complete during study weeks 5–8. Diet quality was assessed at baseline 
and week 8 using the Rapid Eating and Activity Assessment for Patients tool. Fasting venous blood 
samples were collected at study weeks 4 and 8 for vitamin C and histamine analyses. Body and fat 
mass were measured using a calibrated bioelectric impedance scale (TBF-300A Body Composition 
Analyzer, Tanita Corporation of America, Inc., Arlington Heights, IL, USA), and height was measured 
using a mechanical stadiometer. The study was conducted January through April 2011, and data were 
unblinded once blood analyses and data entry were complete. 
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2.3. Survey Measures 
The Wisconsin Upper Respiratory Symptom Survey-21 is a validated measure to assess the 
symptoms and impact of acute upper respiratory tract infections (presumed to be the common  
cold) [19]. Cold symptom severity (10 questions) and the impact of cold symptoms on daily living  
(9 questions) were assessed daily on a 7-point scale from “very mildly” to “severely”. Question scores 
were summed for each category to calculate the total symptom severity score and the total “impact of 
cold on daily living” score. For this research, a cold episode was defined as a daily score of 5 or 
greater for the symptom severity category, indicating either (1) the presence of five different “very 
mild” cold symptoms; (2) the presence of several different cold symptoms, some mild and some more 
moderate in severity; or (3) the presence of a single cold symptom at least moderate in severity. The 
duration of a cold was based on a daily score of 5 or greater on consecutive days. When two episodes 
of sickness were separated by one to three days when reported scores were <5, the episode was 
considered to be a single cold. Since some participants reported cold episodes on the first few days of 
the study, only cold episodes initiating after the 5th day of the study were counted. Cold duration 
(days), cold severity score (daily average), and the “impact of cold on daily living” score (daily 
average) were calculated for the reported cold episodes. 
Leisure-time physical activity levels were assessed using the Godin-Leisure Time Exercise 
Questionnaire that was designed to estimate the energy cost of activities, or metabolic equivalents 
(METS) [20]. This physical activity questionnaire is considered highly reliable and has been validated 
with objective measures of physical activity such as accelerometers and heart rate monitors [20–22]. 
The times per week that mild, moderate, or strenuous exercise were engaged were multiplied by 3, 5, 
and 9 METS respectively and summed to estimate total METS (kcal·kg−1·week−1). For reporting 
purposes, scores for METS were averaged every two weeks during the trial.  
The Rapid Eating and Activity Assessment for Patients (REAPS) tool was designed to rapidly 
assess diets according to the U.S. Dietary Guidelines [23]. The REAPS demonstrated strong agreement 
with the Block Semi Quantitative Food Frequency Questionnaire for fruits, vegetables, milk, and fat 
consumption [24]. The food frequency measure was composed of 10 fruit, vegetable, and fortified food 
categories that represent the common sources of dietary vitamin C. Portion size and weekly serving 
frequency were recorded and used to estimate daily dietary vitamin C intake. 
2.4. Biosample Analyses 
A plasma aliquot was immediately mixed with equal volumes of ice-cold 10% trichloroacetic acid, 
centrifuged at 3500× g for 20 min at 0 °C, and the supernatant stored at −80 °C until analysis for  
vitamin C using the 2,4-dinitrophenylhydrazine colorimetric method [25] with inter-analyses 
coefficients of variation averaging <2.8%. This analysis highly correlates with HPLC methodology 
when fasting blood samples are used [26]. For histamine analysis, plasma was treated with an acylation 
reagent, and the acylated histamine was quantified using a commercial enzyme immunoassay kit 
(ALPCO Immunoassays, Salem, NH, USA). 
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2.5. Statistical Analysis 
Values are expressed as the mean ± SD, and all data analyses were conducted using PASW 
Statistics 19.0 (Predictive Analytics SoftWare Statistics package, IBM, 2009). Based on pilot data, a 
sample of 15 participants per group provided 75% power to detect an 11 µmol/L difference in plasma 
vitamin C. Differences between means were examined using the nonparametric Mann-Whitney U test. 
Average change in outcome measures, 95% CI, and partial eta squared effect size (η2partial) were 
calculated using Univariate Analyses. Effect size describes the magnitude of the difference between 
variables and are interpreted as small (<0.02), medium (0.13) and large (>0.26). Pearson correlation 
was used to examine relationships between variables, and the rate ratio (RR) is reported for cold 
outcomes in the vitamin C supplemented group in comparison to the control group. For all analyses, 
significance was set at p ≤ 0.05. 
3. Results 
Participants were apparently healthy men. Plasma vitamin C concentrations were below adequate 
(<28 µmol/L) for 14 of 30 participants, and two participants were vitamin C deficient (plasma  
vitamin C < 11 µmol/L). Participants were paired by age, BMI and plasma vitamin C concentration 
and randomly assigned to the vitamin C (n = 15) or placebo (n = 15) groups. One participant randomized 
to the placebo group was non-compliant with the capsule protocol and removed from the trial after several 
weeks. An additional participant (also from the placebo group) reported a severe cold that lasted for 
the first 24 days of the trial, and his data were not entered into the analyses leaving 15 participants in 
the vitamin C group and 13 participants in the placebo group. Participants did not report any side 
effects with capsule ingestion. Baseline characteristics did not vary between groups for those 
participants who completed the trial with the exception of physical activity level (Table 1). At baseline 
vitamin C concentrations were inversely correlated with body weight (r = −0.597; p = 0.002), BMI  
(r = −0.523; p = 0.004), and body fat percentage (r = −0.623; p < 0.001). Aside from correlations between 
the adiposity measures, no other significant correlations were noted among baseline characteristics. 
Table 1. Baseline characteristics by group *. 
Characteristic Vitamin C (n = 15) Placebo (n = 13) 
Age (year) 23.0 ± 3.1 23.2 ± 4.3 
Weight (kg) 83.0 ± 9.1 81.6 ± 10.3 
BMI (kg/m2) 24.5 ± 3.9 26.0 ± 3.9 
Body fat (%) 17.5 ± 6.4 20.7 ± 6.5 
Dietary vitamin C (mg/day) 93 ± 53 104 ± 45 
Diet quality score 31.1 ± 3.1 31.2 ± 3.2 
METS (kcal·kg−1·week−1) 57 ± 24 38 ± 22 
Plasma vitamin C (µmol/L) 30.2 ± 8.5 29.1 ± 9.3 
* Values are mean ± SD. There were no significant differences between groups with the exception of METS 
(p = 0.03, Mann-Whitney U test). 
  
Nutrients 2014, 6 2577 
 
 
Fasting plasma vitamin C concentrations were raised significantly for the vitamin C group versus 
the placebo group at week 4 (41.3 ± 10.9 versus 30.8 ± 11.4 µmol/L; p = 0.02) and at week 8 (42.1 ± 
10.4 versus 33.9 ± 10.9 µmol/L; p = 0.05). Diet quality did not change significantly between groups at 
week 8 (REAPS scores, 32.0 ± 3.4 and 30.5 ± 4.7 for the vitamin C and placebo groups respectively); 
furthermore, dietary vitamin C did not differ significantly between groups during the trial (average 
weekly intake, 93 ± 36 and 103 ± 53 mg/day for the vitamin C and placebo groups respectively). 
Physical activity increased slightly in the vitamin C group compared to the placebo group in the 
first four weeks of the trial (+6.2% to +7.5%; p ≥ 0.7); however, at weeks 5–6 and weeks 7–8, physical 
activity increase more markedly in the vitamin C versus placebo groups (+21.2%, 95% CI [−23.7, 
66.1], p = 0.3 and +39.6%, 95% CI [−4.5, 83.7], p = 0.10, respectively) (Table 2). 
Table 2. The energy cost of activities, or metabolic equivalents (METS; kcal·kg−1·week−1) 
in participants ingesting vitamin C (1000 mg) or placebo daily for eight weeks. The data 
are averaged at two-week intervals and presented as the mean value; the percent increase 
from baseline with 95% CI; and the treatment effect *. 
METS Vitamin C (n = 15) Placebo (n = 13) Treatment effect p [η2] 
Week 1–2     
Mean ± SD 68 ± 32 44 ± 25   
Average increase 28.8% 21.3% +7.5% 0.7 
[95% CI] [−3.7, 61.3] [−13.6, 56.2]  [−40.1, 55.2] [0.00] 
Week 3–4     
Mean ± SD 66 ± 27 42 ± 25   
Average increase  21.0% 14.8% +6.2% 0.8 
[95% CI] [−3.9, 45.8] [−11.9, 41.5] [−30.3, 42.6] [0.01] 
Week 5–6     
Mean ± SD 84 ± 41 46 ± 25   
Average increase  51.4% 30.1% +21.2% 0.3 
[95% CI] [20.8, 82.0] [−2.7, 63.0]  [−23.7, 66.1] [0.04] 
Week 7–8     
Mean ± SD 86 ± 39 43 ± 20   
Average increase  60.2% 20.5% +39.6% 0.10 
[95% CI] [30.1, 90.2] [−11.7, 52.8] [−4.5, 83.7] [0.12] 
* p for Univariate analysis; η2 = partial eta squared effect size. 
The number of participants reporting cold episodes was 7 and 11 for the vitamin C supplemented 
versus placebo groups respectively during the eight-week trial (RR = 0.55, 95% CI [0.33, 0.94],  
p = 0.04) (Table 3). The total number of reported colds was 12 and 17 for the vitamin C versus placebo 
groups (RR = 0.66, 95% CI [0.28, 1.55], p = 0.11). Cold duration was reduced 59% in the vitamin C 
versus placebo groups (−3.2 days, 95% CI [−7.0, 0.6]; p = 0.06). Cold severity scores and “impact of 
cold on daily living” scores did not differ between groups (Table 2). The overall mean symptom 
severity score of participants was not related to the average change in weekly METS during the  
8-week trial. 
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Table 3. Cold outcomes in participants ingesting 1000 mg vitamin C versus placebo daily for eight weeks *. 
 
n 
Participants 
with colds 
Total number 
of colds 
Cold duration, days 
(mean ± SD) 
Cold severity score 
(mean ± SD) 
Impact of cold on daily 
living score (mean ± SD)
Vitamin C 15 7 12 2.2 ± 1.4 10.7 ± 6.0 2.6 ± 1.6 
Placebo 13 11 17 5.4 ± 4.5 18.6 ± 17.5 2.4 ± 2.1 
RR or change 95% 
CI  
0.55 a 
[0.33, 0.94]
0.66 a 
[0.28, 1.55] 
−3.2 b 
[−7.0, 0.6] 
−7.9 b 
[−22.5, 6.7] 
0.2 b 
[−1.8, 2.2] 
Effect size c    0.170 0.075 0.003 
p value d  0.04 0.11 0.06 0.54 0.72 
* Severity score: daily average total symptom score (ten items scored individually from 1 “very mild” to 7 “severe”: runny nose, plugged nose, sneezing, sore throat, 
scratchy throat, cough, hoarseness, head congestion chest congestion, feeling tired) for cold episodes. Impact of cold on daily living score: daily average total score (nine 
items scored individually from 1 “very mildly” to 7 “severely”: think clearly, sleep well, breathe easily, walk/climb stairs/exercise, accomplish daily activities, work 
outside the home, work inside the home, interact with others, live your personal life) for cold episodes. a Rate ratio; b treatment effect: average change; c partial eta squared; 
d Mann-Whitney U test or Chi Square test for “Participants with colds”. 
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Histamine concentrations did not correlate significantly with plasma vitamin C concentrations at 
week 8 of the study (r = −0.246, p = 0.207), and histamine concentrations were not impacted by  
eight weeks of vitamin C supplementation (0.667 ± 0.628 and 0.356 ± 0.2427 ng/mL at baseline versus 
0.639 ± 0.277 and 0.431 ± 0.298 ng/mL at week 8 for the vitamin C and placebo groups respectively;  
p = 0.8 for eight-week change by group). However, histamine concentrations at week 8 were 
significantly correlated to the average daily cold severity score (r = 0.653, p = 0.003). Vitamin C 
concentrations at week 4 and at week 8 were also correlated to the average daily cold severity score  
(r = −0.711, p = 0.001 and r = −0.618, p = 0.006, respectively). 
4. Discussion 
These data demonstrate a measureable benefit of vitamin C supplementation for reducing cold 
episodes in young men with low to average vitamin C status. In addition, the data suggest a modest 
benefit of vitamin C supplementation for enhancing weekly activity levels in young men. Several 
large, cross-sectional investigations support a link between vitamin C status and physical activity and 
corroborate early reports that associated preclinical vitamin C deficiency with fatigue and aversion to 
exercise [9–11,27]. However, there is little causal experimental evidence demonstrating the influence 
of vitamin C supplementation on daily physical activity. Placebo-controlled intervention studies have 
documented increased work efficiency during exercise [7] and reduced perception of effort during 
exercise [28] in vitamin C supplementing untrained adults—characteristics that could possibly inspire 
physical activity. The role of vitamin C in promoting physical activity may relate to its antioxidant 
properties since oxidative stress is related to fatigue [29,30]. Vitamin C also possesses neuroprotective 
properties and influences the brain’s oxidative fuel supply [31], processes that may influence a sense 
of wellbeing. 
The marked reduction in cold incidence and cold duration in young men ingesting vitamin C 
supplements adds to a large, and controversial, literature on vitamin C and prevention of the common 
cold. In 1975 Chalmers reviewed eight trials and concluded that there was no benefit of vitamin C 
supplementation for reducing the incidence or severity of colds [32]; however, critics reanalyzed these 
data and concluded that, although the incidence of colds was not impacted, vitamin C supplementation 
did significantly reduce the duration of colds by 21% [33]. Recent systematic reviews on vitamin C 
and the common cold agree that although the incidence of infections does not appear to be impacted by 
vitamin C, vitamin C supplementation is associated with reduced severity and duration of colds [34,35]. 
The most recent Cochrane review on vitamin C and colds examined 29 placebo-controlled trials that 
supplemented at least 200 mg vitamin C daily and concluded that vitamin C did not reduce the 
incidence of colds in the general population; however, in stressed populations, such as marathon 
runners and soldiers, cold incidence was reduced 52% [16]. Furthermore, the review showed that the 
duration of colds was shortened significantly, 8% and 14% for adults and children respectively. Based 
on the evidence to date, it may be that only populations with low vitamin C status, or those experiencing 
extreme physical exertion or cold stress, may experience anti-cold benefits of supplemental vitamin C. 
A specific anti-cold mechanism of vitamin C has not been elucidated but may relate to  
immune-enhancement orchestrated by vitamin C such as improved natural killer cell activities [36] or 
improved lymphocyte proliferation or chemotaxis [37,38]. Although cold duration was impacted by 
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vitamin C supplementation in the present trial, vitamin C did not reduce cold symptom severity as has 
been reported in the systematic reviews. Both the antioxidant and antihistamine properties of vitamin C 
have been implicated in cold symptom relief since oxidative stress and histamine contribute to cold  
severity [39,40]. Interestingly, histamine and vitamin C concentrations were correlated with cold 
symptom severity during the eight-week trial; however, vitamin C supplementation did not alter 
circulating histamine levels in this sample. 
This study is limited by the small sample size. Although participants were screened for purposeful 
exercise and participation in competitive sports, routine physical activity levels did differ significantly 
between groups at baseline limiting the interpretation of the physical activity outcome data. A common 
cold episode was arbitrarily defined in this report, and these data may not be easily compared between 
reports. By design, this study was conducted in winter months and included only men with  
low-to-adequate vitamin C status; hence, generalizability of these results can only be extended to 
similar populations and season. 
5. Conclusions 
These data suggest that measurable health advantages are associated with vitamin C 
supplementation in men with adequate-to-low vitamin C status. This simple dietary strategy to 
promote physical activity and physical health merits further research and the consideration of  
health practitioners. 
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